Preserving LXR by Inhibiting T39: A Step Closer to Treating Atherosclerosis and Steatohepatitis?

Hepatology - United States
doi 10.1002/hep.28946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy